Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Turbine’s AI-powered Cancer Cell Simulations Will Be Used to Identify Novel Disease Positioning Strategies in Cancer Research UK’s Latest Biotech Partnership
Cancer Research Horizons, the innovation engine at the core of the world’s largest private funder […]
IntoCell Enters into Development and License Option Agreement with ADC Therapeutics
IntoCell has announced the signing of a Material Transfer Agreement (MTA) with option to license […]
BICO Group Appoints Marius Balger as New COO
BICO Group is pleased to announce the appointment of Marius Balger as Chief Operating Officer […]
Amneal Announces Strategic European Partnership with Orion Corporation
Amneal Pharmaceuticals, has announced it has signed a long-term license agreement with Orion Corporation to […]
NHS England Appoints Leading Clinicians To Board
NHS England has added a wealth of clinical expertise and experience to its board with […]
BioSpace Names Most Promising New Biopharma Companies to Watch in 2023
BioSpace, the leading life sciences news and careers site, has announced its 2023 selections for […]
Actimed Therapeutics Closes Second Tranche of £10m Seed Financing
Actimed Therapeutics, a UK based clinical stage specialty pharmaceutical company focused on bringing innovation to […]
CNS Pharmaceuticals Appoints Faith L. Charles, JD as Chair of the Board of Directors
CNS Pharmaceuticals, a biopharmaceutical company specializing in the development of novel treatments for primary and […]
NMD Pharma Appoints Mike Heffernan as Chairman of Board of Directors
NMD Pharma A/S, a clinical-stage biotech company developing first-in-class, small molecule ClC-1 inhibitors for neuromuscular […]
Mission Bio and Abiosciences Partner to Co-develop Bioinformatics for Clinical Research Applications in China
Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, and Abiosciences, the single-cell […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more